0001077183-22-000009.txt : 20220208
0001077183-22-000009.hdr.sgml : 20220208
20220208191244
ACCESSION NUMBER: 0001077183-22-000009
CONFORMED SUBMISSION TYPE: 5
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20211231
FILED AS OF DATE: 20220208
DATE AS OF CHANGE: 20220208
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Gilbert Halley E
CENTRAL INDEX KEY: 0001601360
FILING VALUES:
FORM TYPE: 5
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35756
FILM NUMBER: 22603340
MAIL ADDRESS:
STREET 1: C/O IRONWOOD PHARMACEUTICALS, INC.
STREET 2: 100 SUMMER STREET, SUITE 2300
CITY: BOSTON
STATE: MA
ZIP: 02110
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: NEOGENOMICS INC
CENTRAL INDEX KEY: 0001077183
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-TESTING LABORATORIES [8734]
IRS NUMBER: 742897368
STATE OF INCORPORATION: NV
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 9490 NEOGENOMICS WAY
CITY: FORT MYERS
STATE: FL
ZIP: 33912
BUSINESS PHONE: 2397680600
MAIL ADDRESS:
STREET 1: 9490 NEOGENOMICS WAY
CITY: FORT MYERS
STATE: FL
ZIP: 33912
FORMER COMPANY:
FORMER CONFORMED NAME: AMERICAN COMMUNICATIONS ENTERPRISES INC
DATE OF NAME CHANGE: 19990120
5
1
wf-form5_164436554542544.xml
FORM 5
X0306
5
2021-12-31
0
0
0
0001077183
NEOGENOMICS INC
NEO
0001601360
Gilbert Halley E
9490 NEOGENOMICS WAY
FORT MYERS
FL
33912
0
1
0
0
Chief Legal Officer
Common Stock
2021-12-31
5
L
0
177
31.30
A
105263
D
Stock Option (Right to Buy)
42.21
2028-08-17
Common Stock
63331.0
63331
D
These shares were acquired pursuant to NeoGenomics's Employee Stock Purchase Plan (ESPP) during the year ended December 31, 2021. The shares were acquired in transactions exempt from Section 16b-3.
On August 17, 2021, Ms. Gilbert was granted 63,331 stock options. These options vest ratably over the first four anniversary dates of the grant date.
/s/ Halley E. Gilbert
2022-02-08